Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol MAGEA1 contributors: mct/npt - updated : 06-04-2020
HGNC name melanoma antigen family A, 1 (directs expression of antigen MZ2-E)
HGNC id 6796
ASSOCIATED DISORDERS
corresponding disease(s)
Other morbid association(s)
TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
tumoral     --over  
in primary breast tumor in progression, and in hepatocellular carcinoma
tumoral     --other  
dysregulation of expression in hematological malignanciesnot determined solely by the methylation status of the promoter region (in multiple myeloma)
tumoral     --over  
by promoter hypomethylation up-regulates its expression in colorectal carcinomas as well as in gastric cancers and might play a significant role in the development and progression of colorectal carcinomas (Kim 2006)
tumoral     --other  
MAGEA1 expression is associated with good prognosis in neuroblastoma (Grau 2009)
tumoral     --over  
GPC3, MAGE1A and MAGEA3 were increased with advanced tumor stage, size, and nodule numbers in Hepatocellular Carcinoma
tumoral     --other  
expressed in 93p100 endometrioid endometrial cancer grade 3 and 86p100 of serous and clear cell carcinomas
Susceptibility
Variant & Polymorphism
Candidate gene aberrant methylation patterns of MAGEs CpG islands using methylation-special PCRs may be useful for diagnosis of hepatocellular carcinoma
Marker
  • expression of MAGEA1 genes in peripheral blood may act as a poor prognostic marker in patients with lung cancer
  • Therapy target
    SystemTypeDisorderPubmed
    cancerreproductivebreast
    novel target in breast cancer clinical treatment
    cancerskin 
    MAGEA1 may be a potential therapeutic target for melanoma patients
    ANIMAL & CELL MODELS